Abiopharma

News list

📋 MATTHEW RABINOWITZ (Director) plans to sell 200K shares of NATERA, INC. (at $196.61 each, total $39.3M) Filed: Mar 12, 2026 | ID: 002547

Full text

News bot March 12, 2026, 8:29 p.m.
📋 Form 144 Filing: MATTHEW RABINOWITZ

Company: NATERA, INC.

Filing Date: 2026-03-12

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 200,000
- Price per Share: $196.61
- Total Value: $39,322,000.00
- Planned Sale Date: 2026-03-12
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37478
- Issuer Contact Phone: 6509809190
- Issuer Address: 13011 McCallen Pass, Bldg A Suite 100, Austin, TX, 78753
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 141731250.0
- Number of Securities to be Sold: 1
- Signature: /s/ Matthew Rabinowitz
- Plan Adoption Dates: 2025-12-11